OCEA CIK: 1869974

Ocean Biomedical, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium

Price analysis

Chart shows the share price.

Key metrics overview

Metrics score locked — part of Premium
Unlock metrics and scores View Premium
Valuation
Available with Premium/ 100
  • Price-to-Earnings Ratio No meaningful value available
  • Price-to-Sales Ratio Available with Premium
  • Price-to-Free-Cashflow Available with Premium
  • Growth-Adjusted P/E Available with Premium
Growth
Available with Premium/ 100
  • Revenue Growth No meaningful value available
  • Earnings Growth Available with Premium
  • Free Cash Flow Growth Available with Premium
  • Net Margin Change Available with Premium
  • Free Cash Flow Margin Change Available with Premium
  • Earnings-per-Share Growth Available with Premium
  • Growth Consistency Available with Premium
Profita­bility
Available with Premium/ 100
  • Return on Equity No meaningful value available
  • Return on Assets Available with Premium
  • Return on Invested Capital Available with Premium
  • Operating Profit Margin Available with Premium
  • Net Profit Margin Available with Premium
Stability
Available with Premium/ 100
  • Revenue Stability No meaningful value available
  • Earnings Stability Available with Premium
  • Cashflow Stability Available with Premium
  • Crisis Performance Available with Premium
  • Price Fluctuations Available with Premium
  • Maximum Price Loss Available with Premium
Debt
Available with Premium/ 100
  • Debt-to-Equity Ratio Available with Premium
  • Debt-to-Assets Available with Premium
  • Net Debt / EBITDA Available with Premium
  • Interest Coverage Ratio Available with Premium
Cashflow
Available with Premium/ 100
  • Operating Cashflow Available with Premium
  • Free Cashflow Available with Premium
  • Free Cashflow Margin Available with Premium
Dividends
Available with Premium/ 100
  • Dividend Yield Available with Premium
  • Dividend Payout Ratio Available with Premium
  • Dividend Growth Available with Premium
  • Years without a cut Available with Premium

Every metric explained simply

Market comparison

Ranking unavailable

No ranking can be calculated for this company at the moment.

Revenue and Profit Performance

Data table: Revenue and Profit Performance (M USD)
Point in timeRevenueProfit
FY24 (Dec 31, 2024)0 M USD−9.5 M USD
FY23 (Dec 31, 2023)0 M USD−114.5 M USD
FY22 (Dec 31, 2022)0 M USD−17.4 M USD
FY21 (Dec 31, 2021)0 M USD−62.3 M USD
FY20 (Dec 31, 2020)0 M USD−1.7 M USD
FY19 (Dec 31, 2019)0 M USD−0.2 M USD

All amounts in millions USD Data sources:SEC EDGARTwelve Data